Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Serum Adiponectin Levels and Insulin Resistance in Obese Children

비만 소아의 혈중 아디포넥틴과 인슐린저항성에 관한 연구

  • Lee, Hee-Sun (Department of Pediatrics, College of Medicine, Korea University) ;
  • Lee, Jin (Department of Pediatrics, College of Medicine, Korea University) ;
  • Kang, Min-Joo (Department of Pediatrics, College of Medicine, Korea University) ;
  • Choi, Byung-Min (Department of Pediatrics, College of Medicine, Korea University) ;
  • Lee, Kee-Hyoung (Department of Pediatrics, College of Medicine, Korea University)
  • 이희선 (고려대학교 의과대학 소아과학교실) ;
  • 이진 (고려대학교 의과대학 소아과학교실) ;
  • 강민주 (고려대학교 의과대학 소아과학교실) ;
  • 최병민 (고려대학교 의과대학 소아과학교실) ;
  • 이기형 (고려대학교 의과대학 소아과학교실)
  • Received : 2005.01.27
  • Accepted : 2005.03.07
  • Published : 2005.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Adiponectin, adipose tissue-specific protein, has anti-inflammatory and anti-atherogenic properties. It has been found to have a negative correlation with obesity and to play a role in modulating glucose tolerance and insulin sensitivity. Serum adiponectin concentrations are decreased in adults with obesity and type 2 diabetes. We investigated the difference in adiponectin levels between obese and non-obese children, and evaluated the relationship of serum adiponectin with body mass index(BMI), serum fasting insulin, lipid profiles and homeostasis model assessment(HOMA) in children. Methods : We measured serum adiponectin levels by radioimmunoassay in 113 children(82 obese children and 31 non-obese controls) from 8 to 15 years of age, and also checked BMI, fasting serum glucose, insulin and lipid profiles. Fasting and postprandial serum adiponectin concentrations were compared by oral glucose tolerance tests in 27 obese children. The correlations of adiponectin with BMI, insulin, low density lipoprotein(LDL)-cholesterol and HOMA were analyzed by Pearson's correlation. Results : The serum adiponectin levels were significantly lower in the obese group(19.7 mg/mL) than in the non-obese group(27.5 mg/mL)(P<0.01). Serum adiponectin concentrations were negatively correlated with BMI(r=-0.39, P<0.01), serum insulin(r=-0.28, P<0.01), LDL-C(r=-0.20, P<0.01) and HOMA(r=-0.22, P<0.01). At oral glucose tolerance tests in obese children, postprandial 2 hours adiponectin level(19.8 mg/mL) was decreased compared to fasting level(25.8 mg/mL)(P<0.01). Conclusion : Serum adiponectin concentrations were inversely related to adiposity and insulin resistance in children. We suggest the serum adiponectin level could be used as an early marker of insulin resistance in obese children.

목 적 : 식생활과 생활양식의 서구화로 인하여 우리나라도 비만의 유병률이 급격히 증가하는 추세이며 특히 소아비만은 이미 소아기에 합병증 발생의 위험과 더불어 성인비만으로 이행될 가능성이 크기에 이에 대한 관심이 날로 높아지고 있는 추세이다. 아디포넥틴은 최근 발견된 지방세포에서 분비되는 adipocytokine으로 비만에서 아디포넥틴의 감소가 인슐린저항성과 동맥경화증의 발병과 관련이 있는 것으로 알려져 있다. 본 연구는 비만아와 정상 체중아의 혈중 아디포넥틴 농도의 차이와 체질량지 수(BMI) 및 인슐린저항성과의 상관관계를 알아보고자 하였다. 방 법 : 2003년 1월부터 2003년 6월까지 BMI가 95 백분위 이상인 8-15세 사이의 비만아 82명(남아 54명, 여아 28명)과 대조군으로 정상 체중아 31명(남아 21, 여아10), 총 113명을 대상으로 신체계측을 하고 공복 후 채혈하여 혈중 아디포넥틴, 인슐린, 혈당 농도를 측정하였다. 혈중 아디포넥틴 농도를 비만여부와 사춘기 시기별로 비교하였으며 아디포넥틴과 체질량지수, 인슐린, HOMA 등과의 상관관계를 알아보았다. 결 과 : 1) 비만아의 평균 혈중 아디포넥틴 농도는 19.7 mg/mL, 정상 체중아는 27.6 mg/mL로 비만군이 유의하게 낮았으며(P<0.01), 전체 대상아 중 남아와 여아의 성별에 따른 차이는 없었다. 2) 사춘기 전보다 사춘기 시기의 소아에서 아디포넥틴의 농도가 의미있게 낮았다(P<0.01). 3) 비만아 중 27명을 대상으로 시행한 경구 당부하 검사에서 공복시에 비해 식후 2시간 후 인슐린 농도는 유의하게 높았으며($17.0{\mu}IU/mL$ vs $35.8{\mu}IU/mL$, P<0.01), 아디포넥틴 농도는 반대로 유의하게 낮았다(25.8 mg/mL vs 19.8 mg/mL, P<0.01). 4) 혈중 아디포넥틴과 BMI(r=-0.39, P<0.01), 인슐린(r=-0.28, P<0.01)은 각각 음의 상관관계를 보였으며, 혈중 지질치중 저밀도 지질단백(LDL) 콜레스테롤(r=-0.20, P<0.05)과도 음의 상관관계를 보였으나 총 콜레스테롤과 고밀도 지질단백(HDL) 콜레스테롤과, 중성지방과는 유의한 상관관계가 없었다. 결 론 : 혈중 아디포넥틴 농도는 비만아에서 정상 체중아보다 유의하게 낮았으며, 아디포넥틴은 BMI 및 혈중 인슐린과 음의 상관관계가 있었다. 혈중 아디포넥틴이 소아 비만아에서 인슐린 저항성의 예측인자로 유용하게 사용될 수 있을 것으로 생각된다.

Keywords

References

  1. Park YS, Lee DH, Choi JM, Kang YJ, Kim CH. Trend of obesity in school age children in Seoul over the past 23 years. Korean J Pediatr 2004:47:247-57
  2. Yim IS. Diagnosis of childrenhood obesity. J Korean Soc Study Obesity 2003;12 Suppl 3:95-107
  3. Knerr I. Obesity and the metabolic syndrome in children and adolescents. MMW Fortschr Med 2004;146:41-3
  4. Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA 2004;101:10302-7 https://doi.org/10.1073/pnas.0403760101
  5. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9 https://doi.org/10.1161/01.ATV.20.6.1595
  6. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004;27:2450-7 https://doi.org/10.2337/diacare.27.10.2450
  7. Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, Engelman L, et al. Adipocytokines, body composition, and fitness in children. Pediatr Res 2003;53:148-52 https://doi.org/10.1203/00006450-200301000-00025
  8. Ouchi, N, Kihara, S, Arita, Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-6 https://doi.org/10.1161/01.CIR.100.25.2473
  9. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277: 25863-6 https://doi.org/10.1074/jbc.C200251200
  10. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004;344:1-12 https://doi.org/10.1016/j.cccn.2004.02.020
  11. Lihn AS, Ostergard T, Nyholm B, Pedersen SB, Richelsen B, Schmitz O. Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2003;284:443-8 https://doi.org/10.1152/ajpendo.00358.2002
  12. Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS, et al. Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 2004; 317:1045-51 https://doi.org/10.1016/j.bbrc.2004.03.152
  13. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6 https://doi.org/10.1038/90984
  14. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponec tin. J Clin Endocrinol Metab 2001;86:3815-9 https://doi.org/10.1210/jc.86.8.3815
  15. Fruebis J. Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001;98:2005-10
  16. Park JY, Choi SJ, Kim KH, Hong YM, Lee K. A study for adiponectin in obese adolescents with hypertension. Korean J Pediatr 2004:47:719-25
  17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9 https://doi.org/10.1007/BF00280883
  18. Must A, Spadono J. Coakley EH, Field AE, Cclditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9 https://doi.org/10.1001/jama.282.16.1523
  19. Park SO. Drug approach for reducing inflammation in obesity. J Korean Soc Study Obesity 2003;12 Suppl 3:23-8
  20. Park SH, Lee KH, Lee JH, Shin YK, Eun BL, Kim SK. Serum leptin levels in children according to pubertal stage. J Korean Pediatr Endocrinol 2000;5:201-9
  21. Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K, et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003;11:1072-9 https://doi.org/10.1038/oby.2003.147
  22. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004;89:3790-4 https://doi.org/10.1210/jc.2003-031925
  23. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277: 25863-6 https://doi.org/10.1074/jbc.C200251200
  24. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83 https://doi.org/10.1006/bbrc.1999.0255
  25. Shand BI, Scott RS, Elder PA, George PM. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 2003;5:349-53 https://doi.org/10.1046/j.1463-1326.2003.00279.x
  26. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, et al.Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol 2004;61:75-80 https://doi.org/10.1111/j.1365-2265.2004.02063.x
  27. Hirose H, Kawai T, Yamamoto Y, Taniyama M, Tomita M, Matsubara K, et al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 2002;51:314-7 https://doi.org/10.1053/meta.2002.30506
  28. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO, et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 2004;89:2697-703 https://doi.org/10.1210/jc.2003-031826
  29. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children : relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002;87:4652-6 https://doi.org/10.1210/jc.2002-020694
  30. Tsou PL, Jiang YD, Chang CC, Wei JN, Sung FC, Lin CC, et al. Sex-related differences between adiponectin and insulin resistance in school children. Diabetes Care 2004;27:308-13 https://doi.org/10.2337/diacare.27.2.308
  31. Hara T, Fujiwara H, Shoji T, Mimura T, Nakao H, Fujimoto S. Decreased plasma adiponectin levels in young obese males. J Atheroscler Thromb 2003;10:234-8 https://doi.org/10.5551/jat.10.234
  32. Bottner A, Kratzsch J. Muller G, Kapellen TM, Bluher S, Keller E, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004;89: 4053-6l https://doi.org/10.1210/jc.2004-0303
  33. Islam AH, Yamashita S, Kotani K, Nakamura T, Tokunaga K, Arai T, et al. Fasting plasma insulin level is an important risk factor for the development of complications in Japanese obese children-i-results from a cross-sectional and a longitudinal study. Metabolism 1995:44:478-85 https://doi.org/10.1016/0026-0495(95)90055-1
  34. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000; 11:351-6 https://doi.org/10.1016/S1043-2760(00)00323-4
  35. Kraegen EW, Cooney GJ, Ye J, Thompson AL. Triglyceri des, fatty acids and insulin resistance--hyperinsulinemia. Exp Clin Endocrinol Diabetes 2001;109:516-26 https://doi.org/10.1055/s-2001-15114
  36. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004;27:547-52 https://doi.org/10.2337/diacare.27.2.547
  37. Ahn SY, Shin CH, Yang SW. Indices of insulin resistance in children with simple obesity. J Korean Pediatr Endocrinol 2004;9:42-9